India’s drug controller is allowing Abbott’s coronary stent, Absorb BVS, to start fresh clinical trials, though it has been red-flagged by the US and Australia.
As the agitation in Manipur’s hill district crosses its 600th day and eight bodies still await burial, the protesters witnessed their struggle nearly reach a resolution this month, but then suddenly head back into a deadlock.
With fake news proliferating on social media, journalists and news organisations in the US and Europe are collaborating to come up with a counter-strategy.
At the Supreme Court’s asking, a rights group in Manipur is sorting through files pertaining to over 1,528 victims of alleged extra-judicial killings to place before the judges.
Although using the drug enables dairy and horticulture farmers to gain more profits, it puts both their livestock and consumers at great risk.
In a wide-ranging interview with The Wire, the outgoing secretary of the AYUSH ministry, Ajit M. Sharan, says the rules to the Drugs and Cosmetics Act will soon be changed to have strict guidelines for safety trials of AYUSH medicines.
The debate and discussion that went into this Bill stand in stark contrast to other recent ‘backdoor’ parliamentary decisions, such as the Finance Bill.
Solidarity Grows for Maharashtra’s Agitating Doctors Ahead of Meet With Fadnavis Over Security Issues
Doctors across Maharashtra and in other places have been on strike, protesting against the lack of security in hospitals and attacks on medical professionals.
The Bill was passed without amending the contentious clause that puts no legal obligation on the state if a patient is denied treatment.
Explaining what ‘non-governmental’ means, two bureaucrats clarified it meant both NGOs as commonly understood as charitable organisations as well as private for-profit organisations.
The new policy unveiled in parliament also envisages an increase in the health budget to 2.5% of GDP but only by 2025.